Palvella Therapeutics, Inc.
PVLA· Nasdaq
PVLAPalvella Therapeutics, Inc.
Filed May 14, 2015 · 10-Q · 44 days after period end · 0001193125-15-187272
| Metric | Q1 2015 | Q1 2014 |
|---|---|---|
| Revenue | $217.62K | $1.37M |
| Net Income | -$3.70M | -$779.91K |
| EPS Diluted | -$0.13 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Palvella Therapeutics, Inc. · CIK 1583648 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 14, 2015 · 44 d after period end
